Urethral Urothelial Carcinoma
5 clinical trials · Condition
◉ Watch Urethral Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer (NCT03617913) | Mayo Clinic | 2018-09-19 |
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery (NCT02812420) | M.D. Anderson Cancer Center | 2017-03-07 |
| Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer (NCT02437370) | University of California, Davis | 2015-09-01 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208) | National Cancer Institute (NCI) | 2015-07-22 |
| Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery (NCT02178241) | National Cancer Institute (NCI) | 2014-12-11 |
Track Urethral Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.